Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT/Sp1/MMP1 axis

Yat-Yin Law1,2,3, Hsiang-Lin Lee1,4, Chu-Liang Lin3

  • 1School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

PubMed

Insights

Asiatic acid (AA) shows potential against osteosarcoma by inhibiting cancer cell migration and invasion. It targets the p-AKT/Sp1/MMP1 pathway, offering a new avenue for treating this bone cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Osteosarcoma is a prevalent bone cancer in children and adolescents with limited treatment options.
  • Asiatic acid (AA), derived from Centella asiatica, exhibits known anti-tumor properties in various cancer cell types.
  • Investigating novel therapeutic agents for osteosarcoma is crucial due to the lack of effective treatments.

Purpose of the Study:

  • To evaluate the antitumor effects of Asiatic acid (AA) on human osteosarcoma cells.
  • To elucidate the molecular mechanisms underlying AA's action in osteosarcoma.
  • To explore the potential of AA as a therapeutic agent for osteosarcoma.

Main Methods:

  • Cell viability, proliferation, and cell cycle assays were performed.
  • Cell migration and invasion assays were conducted.
  • Gene expression analysis (MMP1, Sp1) and Western blotting (p-AKT) were utilized.
  • Bioinformatic analysis of the TNMplot database was performed.

Main Results:

  • Asiatic acid (AA) did not affect osteosarcoma cell viability, proliferation, or cell cycle.
  • AA significantly suppressed osteosarcoma cell migration and invasion by down-regulating MMP1 expression.
  • AA reduced Sp1 expression and AKT phosphorylation, key components of the p-AKT/Sp1/MMP1 pathway.
  • MMP1 overexpression reversed AA's anti-migratory and anti-invasive effects, while Sp1 overexpression abolished AA's efficacy.

Conclusions:

  • Asiatic acid (AA) demonstrates anti-invasive and anti-migratory effects on human osteosarcoma cells.
  • The anti-cancer activity of AA is mediated through the p-AKT/Sp1/MMP1 signaling pathway.
  • AA holds promise as a potential therapeutic candidate for osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K